| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-16 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-10 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-10 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-10 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.26 | 8e-09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.27 | 7e-06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-05 |